Article

Elevated acylcarnitines C4 and C5 in cerebrospinal fluid distinguish viral CNS infections from autoimmune neuroinflammation

2023-09-12

Abstract excerpt

<title>Abstract</title> <p>Background. Viral and autoimmune encephalitis may present with similar symptoms, but require different treatments. Thus, there is a need for biomarkers to improve diagnosis and understanding of pathogenesis. We hypothesized that virus-host cell interactions effect different changes in central nervous system (CNS) metabolism than autoimmune processes and searched for metabolite biomarke...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8fc5e890-7e60-5359-9885-4ed7de2551b3
DOI: 10.21203/rs.3.rs-3313809/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Elevated acylcarnitines C4 and C5 in cerebrospinal fluid distinguish viral CNS infections from autoimmune neuroinflammationDOI 10.21203/rs.3.rs-3313809/v1Read

A multi-omics analysis of CSF reveals the differential immunopathology molecular mechanisms underlying viral encephalitis and autoimmune encephalitisSemantic proximity Read

Improving the diagnosis of encephalitis through analysis of the host transcriptome, proteome and metabolomeSemantic proximity Read

Integrative metabolomics reveals unique metabolic traits in Guillain-Barré Syndrome and its variantsSemantic proximity Read

Molecular markers in the CSF proteome differentiate neuroinflammatory diseasesSemantic proximity Read

Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndromeSemantic proximity Read

The Brain Reacting to COVID-19: Analysis of the Cerebrospinal Fluid and Serum Proteome,Transcriptome and Inflammatory ProteinsSemantic proximity Read

Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative updateSemantic proximity Read

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read

Utility of an untargeted metabolomics approach using a 2D GC-GC‒MS platform to distinguish relapsing and progressive multiple sclerosisSemantic proximity Read

Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosisSemantic proximity Read

Metabolomics reveals lipid and amino acid signatures of disease severity in multiple sclerosisSemantic proximity Read

Toward a Unified Neuroimmune Framework for Infection-Associated Psychiatric DisordersSemantic proximity Read